Clinical trial
Trastuzumab and Chemotherapy Followed by Surgery and Combination Chemotherapy in…
NCT00009997 · NYU Langone Health, Other · Completed
Key facts
| NCT number | NCT00009997 |
|---|---|
| Title | Trastuzumab and Chemotherapy Followed by Surgery and Combination Chemotherapy in Treating Women With Locally Advanced Breast Cancer |
| Official title | Herceptin and Paclitaxel in Locally Advanced Breast Cancer With Her-2 Overexpression |
| Lead sponsor | NYU Langone Health, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Biological, Drug, Procedure |
| Interventions | trastuzumab, cyclophosphamide, doxorubicin hydrochloride, paclitaxel, tamoxifen citrate, conventional surgery |
| Start date | Mar 1, 1999 |
| Primary completion | Jan 1, 2004 |
| First posted | Feb 3, 2004 |
| Last update posted | Mar 28, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: